about
Neurological damage in MSUD: the role of oxidative stress.Eugenol derivatives as potential anti-oxidants: is phenolic hydroxyl necessary to obtain an effect?Inhibition of creatine kinase activity in vitro by ethylmalonic acid in cerebral cortex of young rats.Ethylmalonic acid inhibits mitochondrial creatine kinase activity from cerebral cortex of young rats in vitro.Green juice as a protector against reactive species in rats.Globotriaosylceramide is correlated with oxidative stress and inflammation in Fabry patients treated with enzyme replacement therapy.Effect of short- and long-term exposition to high phenylalanine blood levels on oxidative damage in phenylketonuric patients.Cytotoxic and apoptotic effects of chalcone derivatives of 2-acetyl thiophene on human colon adenocarcinoma cells.Amino acids levels and lipid peroxidation in maple syrup urine disease patients.Oxidative stress in patients with phenylketonuria.Maple syrup urine disease in treated patients: biochemical and oxidative stress profiles.Synthesis and antioxidant activity of 3-(Pyridin-2-ylmethyl)-1,3-thiazinan(thiazolidin)-4-ones.Oxidative stress in plasma from maple syrup urine disease patients during treatment.Hexacosanoic and docosanoic acids plasma levels in patients with cerebral childhood and asymptomatic X-linked adrenoleukodystrophy: Lorenzo's oil effect.Concurrent folate treatment prevents Na+,K+-ATPase activity inhibition and memory impairments caused by chronic hyperhomocysteinemia during rat development.Induction of lipid peroxidation and decrease of antioxidant defenses in symptomatic and asymptomatic patients with X-linked adrenoleukodystrophy.Oxidative stress parameters in diabetic rats submitted to forced swimming test: the clonazepam effect.Acute administration of methionine and/or methionine sulfoxide impairs redox status and induces apoptosis in rat cerebral cortex.Investigation of oxidative stress parameters in treated phenylketonuric patients.Inhibition of the electron transport chain and creatine kinase activity by ethylmalonic acid in human skeletal muscle.Pharmacological application of antiradical compound properties.Erythrocyte glutathione peroxidase activity and plasma selenium concentration are reduced in maple syrup urine disease patients during treatmentAntioxidant capacity and environmentally friendly synthesis of dihydropyrimidin-(2H)-ones promoted by naturally occurring organic acidsIn vitro effect of globotriaosylceramide on electron transport chain complexes and redox parameters
P50
Q38162092-A55DE5F4-EB0A-4A2B-9638-3E25ECE06E6CQ44078845-E678C160-187E-48A3-815B-079F25D77DF1Q44270683-7A63E514-6B7D-4832-B902-94967073F2ABQ44418173-D62E42FA-77E2-4A96-801E-8CBFEFADF43AQ45788289-28DC0F90-B930-4980-95B2-40CD0A75CFE4Q45860403-99FE4729-6F2E-4A40-8D61-2CFA3B2EDC8FQ46017779-ADC02962-E9C6-46F3-A2D5-72CE991AD0ACQ46045100-C2753A6F-ACEE-4BE8-B43C-5D32ABE6F3BAQ46176428-6E0A390D-1E7F-4251-8B17-7AA92D9C8073Q46476925-74460D2D-358C-41F7-AD79-599955F7301EQ46844041-E5D1E3CC-160E-41F3-A81B-486DAB922F58Q46878162-67D4755F-5DC4-44AC-9F35-4F9661C547F5Q46890673-17A637BB-EC6B-4DD5-A17B-6A45A8BAE554Q46890676-24D5A89E-0F87-4AE3-AECD-DABCAD0A1DEBQ46893254-65CCDFD5-71D1-4B52-8DEE-5A9BC8ACEDC3Q46957027-F82E7029-230A-49A1-B09B-EB77E18382A0Q48174257-0B90AB2A-E228-493D-A71E-B56794A30AC3Q48211859-E92A84F5-FD3A-4FFC-8D75-7DA1D118E22FQ48347570-6B504FED-041D-481A-B9FB-6928FA745D1FQ48497388-BF88C344-52E0-4F45-9949-4F92CD4EC7ADQ54480662-1830FC69-6F14-440D-81D7-8586796B0B9FQ80490846-61876938-1034-42A9-9A51-3D53D0CDDE26Q83742408-4939E48A-58CD-4673-AD92-EBF4D55E270EQ93042176-688B2750-FFCF-4A3C-B1DA-FAAA741F14FD
P50
description
researcher
@en
name
Alethea G Barschak
@en
Alethea G Barschak
@nl
type
label
Alethea G Barschak
@en
Alethea G Barschak
@nl
prefLabel
Alethea G Barschak
@en
Alethea G Barschak
@nl
P106
P31
P496
0000-0002-3399-5652